 Nektar Therapeutics NASDAQ:NKTR CFO Gil M. Labrucherie sold 6,245 shares of the businesss stock in a transaction dated Monday, August 17th. The shares were sold at an average price of 19.67, for a total transaction of 122,839.15. The sale was disclosed in a legal filing with the Securities Exchange Commission, which is accessible through ... 